APLS - Apellis Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$62.00
DETAILS
HIGH:
$83.00
LOW:
$41.00
MEDIAN:
$62.00
CONSENSUS:
$62.00
UPSIDE:
51.11%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 0 | $0 | -- | -186,853 | SOLD |
| Soros | 0 | $0 | -- | -1,056,000 | SOLD |
| Dalio | 0 | $0 | -- | -34,913 | SOLD |
| Greenblatt | 0 | $0 | -- | -78,750 | SOLD |
| Wood | 0 | $0 | -- | -4,183,918 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 232,903 | $10.03 | $2.3M |
| 2026-05-14 | Dunlop A. Sinclair | director | D-Return | 11,199 | $31.91 | $357K |
| 2026-05-14 | Dunlop A. Sinclair | director | U-Tender | 161,567 | $4.00 | $646K |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | A-Award | 16,150 | -- | -- |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | A-Award | 8,394 | -- | -- |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | A-Award | 8,075 | -- | -- |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | D-Return | 15,114 | $52.66 | $796K |
| 2026-05-14 | Chopas James George | officer: VP/Chief Accounting Officer | D-Return | 21,750 | $65.41 | $1.4M |
| 2026-05-14 | Dolsten Mikael | director | D-Return | 24,135 | $20.96 | $506K |
| 2026-05-14 | FONTEYNE PAUL R. | director | D-Return | 27,600 | $57.20 | $1.6M |
| 2026-05-14 | FONTEYNE PAUL R. | director | D-Return | 5,748 | $59.86 | $344K |
| 2026-05-14 | FONTEYNE PAUL R. | director | U-Tender | 30,666 | $4.00 | $123K |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 23,958 | $14.95 | $358K |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 82,500 | $19.39 | $1.6M |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 34,533 | $66.30 | $2.3M |
| 2026-05-14 | Sullivan Timothy Eugene | officer: Chief Financial Officer | D-Return | 58,140 | -- | -- |
| 2026-05-14 | Machiels Alec | director | D-Return | 3,544 | -- | -- |
| 2026-05-14 | Machiels Alec | director | D-Return | 11,199 | $31.91 | $357K |
| 2026-05-14 | Machiels Alec | director | D-Return | 7,441 | $51.71 | $385K |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | A-Award | 41,250 | -- | -- |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | A-Award | 10,030 | -- | -- |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | D-Return | 110,000 | $14.95 | $1.6M |
| 2026-05-14 | Deschatelets Pascal | officer: Chief Scientific Officer | D-Return | 95,000 | $13.85 | $1.3M |
| 2026-05-14 | Chan Gerald | director | D-Return | 14,684 | $25.12 | $369K |
| 2026-05-14 | Chan Gerald | director | U-Tender | 25,666 | $0.00 | $2 |